Strides  Pharma Science  Limited  (Strides)  has announced that its 50:50 JV Strides Vivimed Pte. Ltd, Singapore has received approval for Albendazole Tablets USP 200 mg from the United States Food & Drug Administration (US FDA).

This is the second generic approval by US FDA for Albendazole Tablets.

Albendazole Tablets is a generic version of Albenza Tablets of Amneal Pharmaceuticals, Inc.

According  to  IQVIA  MAT  data,  the  US  market  for  Albendazole  Tablets  USP  200  mg  is approximately US$ 100 Million.  

Albendazole  is  an  anthelmintic  medication  used  to  treat  certain  infections  caused  by tapeworm.  Albendazole  prevents  newly  hatched  insect  larvae  (worms)  from  growing  or multiplying in the body.